ResMed, Inc. (RMD) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $178.85 +0.70%
EPS Growth %: +14.9%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +14.9%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $397.8 million versus the consensus estimate of $401 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- 'A moment of truth' for Tesla and Musk is here - Wedbush
- Wells Fargo on Super Micro Computer (SMCI): 'No Positive Preannouncement
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
